Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice

other OA: gold public-domain-us
AI-generated summary by claude@2026-06+body, 2026-06-11

This study investigated the enhanced transplantability of human ovarian cancer cell lines in nude mice following pretreatment with cyclophosphamide.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

The paper evaluated whether cyclophosphamide pretreatment of nude mice could enhance the ability to engraft and transplant human ovarian cancer cell lines as xenografts. Using cyclophosphamide-pretreated versus untreated nude mice, the authors reported improved transplantability in the pretreated group, indicating a higher success rate for establishing tumor take. A major limitation is that the study is focused on xenograft engraftment performance rather than on underlying tumor biology or therapeutic efficacy. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 798 characters · extracted from oa-doi-fallback · click to expand
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 24 print issues and online access 251,40 € per year only 10,48 € per issue Buy this article - Purchase on SpringerLink - Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout Rights and permissions About this article Cite this article Nauta, M., Boven, E., Schlüper, H. et al. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice. Br J Cancer 54, 331–335 (1986). https://doi.org/10.1038/bjc.1986.181 Issue date: DOI: https://doi.org/10.1038/bjc.1986.181 This article is cited by - Human tumor xenografts as model for drug testing CANCER AND METASTASIS REVIEW (1988)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Cyclophosphamide Killer Cells, Natural Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Animals Cell Line Cyclophosphamide Cystadenocarcinoma Cystadenocarcinoma Endometriosis Endometriosis Female Humans Killer Cells, Natural Mice Mice, Nude Neoplasm Transplantation

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

SciLite annotations

organisms 2
human transgenic mice
chemicals 1
cyclophosphamide

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:09:35.489789+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine